Prevent the spread of coronavirus and reduce the laboratory strain: this is imaginable with the NADAL antigen check® Covid-19 from Germany whether in schools, nursing homes, hospitals, companies, at the airport or at major events: the result is unbeatable in just 15 minutes. The immediate new control of the medical generation company von minden GmbH is already approved in Europe and must be carried out immediately. Superior quality has been verified several times.
“With NADAL antigen check® Covid-19, we developed a check for the general public. This allows more people to be monitored for Covid-19, meaning that any inflamed individual can be detected and other people protected. “, says Roland Meissner, CEO of nal von minden GmbH, founded in Moers, Germany.
What’s so special about the new check? On the one hand, it’s speed. The result is in a position in just 15 minutes. The control is performed on site and does not want to be sent to the lab. On the other hand, they are functionality data. Roland Meissner: “Our NADAL® Covid-19 antigen control has a diagnostic specificity of more than 99. 9% and a diagnostic sensitivity of 97. 56%. This compares favorably with our well-known competitors. ” Specificity helps to know if all other marked healthy people identify as healthy. Sensitivity indicates whether all Americans with poor health in control are identified as in poor health.
Meissner: “The labs are falling behind lately and want to be relieved. In addition, there is a foreign shortage of reagents on the horizon. Our immediate control, in other words, patient-oriented in vitro diagnosis, can contribute to this. “
For the new antigenArray a mouth pattern or nasopharynx is taken through medical staff. The pattern is extracted into a buffer solution and then channeled to the cassette. As with a pregnancy system, the result is easily readable.
Contact: Gabriele Hellwig, info@hellwig-pr. de, 494038662480